Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TLR4 | O00206 | 1/20 | 0.31 |
| ▸ | PTPRC | P08575 | 3/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.31 |
| ▸ | PTPRB | P23467 | 3/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.31 |
| ▸ | GSTA1 | P08263 | 2/20 | 0.31 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
| ▸ | CREB1 | P16220 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25328268 | 0.92 | PTGS1 (0.33) | LTA4HPTGS1PTGS2CYP1A2CYP2C19 | |
| SCHEMBL25329110 | 0.92 | PTGS1 (0.33) | LTA4HPTGS1PTGS2 | |
| SCHEMBL25329044 | 0.88 | PTGS1 (0.33) | LTA4HPTGS1PTGS2 | |
| SCHEMBL25329527 | 0.88 | LTA4H (0.40) | LTA4HCYP1A2CYP2C19TLR4GSTA1 | |
| SCHEMBL25329550 | 0.84 | LTA4H (0.35) | LTA4HPTGS1PTGS2TLR4PTPRC | |
| SCHEMBL25329867 | 0.82 | CYP1A2 (0.37) | LTA4HCYP1A2CYP2C19GAA | |
| SCHEMBL28975000 | 0.82 | LTA4H (0.36) | LTA4HPTGS1PTGS2TLR4PTPRC | |
| SCHEMBL25328718 | 0.82 | LTA4H (0.36) | LTA4HPTGS1PTGS2TLR4PTPRC | |
| SCHEMBL25327716 | 0.82 | PTGS1 (0.32) | LTA4HPTGS1PTGS2 | |
| SCHEMBL25329481 | 0.82 | PTGS1 (0.32) | LTA4HPTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583813-B2 | Polymerization inhibitors | BASF SE (DE) | 2026-03-24 | — | — | US | disclosed |
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
| CN-115697954-A | Polymerization inhibitor | 巴斯夫欧洲公司 | 2023-02-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | RCE1, CABLES1, DPYD | LTA4H 1432/4885PTGS1 474/4885PTGS2 594/4885 |
| US-12583813-B2 | Polymerization inhibitors | PTGS1, PTGER1, POT1 | LTA4H 323/4885PTGS1 1/4885PTGS2 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.